Eikon Therapeutics
EIKN
#7922
Rank
S$0.51 B
Marketcap
S$9.56
Share price
-0.40%
Change (1 day)
N/A
Change (1 year)

Revenue for Eikon Therapeutics (EIKN)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Eikon Therapeutics from 2025 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A
2025 N/A